Chronic oral anticoagulant therapy in carotid artery stenting: The un-necessity of perioperative bridging heparin therapy

Thrombosis Research

Volumn 130, Issue 1, 2012, Pages 12-15

  Pini, Rodolfo ^a   Faggioli, Gianluca ^a   Mauro, Raffaella ^a   Gallinucci, Sara ^a   Freyrie, Antonio ^a   Gargiulo, Mauro ^a   Stella, Andrea ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bridging heparin therapy; Carotid artery stenosis; Carotid artery stenting; Oral anticoagulant therapy

Indexed keywords

CLOPIDOGREL; HEPARIN;

AGED; ANIMAL TISSUE; ANTICOAGULANT THERAPY; AORTA ARCH; ARTICLE; BLEEDING; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CORRELATIONAL STUDY; COW; DEATH; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HEPARINIZATION; HUMAN; INCIDENCE; MALE; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE; TRANSITIONAL BLINDNESS; TREATMENT DURATION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CAROTID ARTERIES; CAROTID STENOSIS; FEMALE; HEPARIN; HUMANS; MALE; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 84861836680     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.09.031     Document Type: Article

References (26)

1. American Heart Association Heart disease and stroke statistics update 2001 American Heart Association Dallas, TX
2. J.D. Douketis, P.B. Berger, A.S. Dunn, A.K. Jaffer, A.C. Spyropoulos, and R.C. Becker Peroperative management of anticoagulant therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 8th edition Chest 133 (6 Suppl) 2008 299S 339S
3. S.L. Amorosi, K. Tsilimingras, D. Thompson, J. Fanikos, M.C. Weinstein, and S.Z. Goldhaber Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation Am J Cardiol 93 4 2004 509 511
4. A.C. Spyropoulos, F.J. Frost, J.S. Hurley, and M. Roberts Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy Chest 125 5 2004 1642 1650
5. J.L. Goldstein, L.R. Larson, B.D. Yamashita, J.M. Fain, and G.T. Schumock Low molecular weight heparin versus unfractionated heparin in the colonoscopy peri-procedure period: a cost modeling study Am J Gastroenterol 96 8 2001 2360 2366
6. A.C. Spyropoulos, A.G. Turpie, A.S. Dunn, J. Spandorfer, J. Douketis, and A. Jacobson Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry J Thromb Haemost 4 6 2006 1246 1252
7. A.C. Spyropoulos, and A.G. Turpie Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation Curr Opin Pulm Med 11 5 2005 373 379
8. J.M. Spandorfer, S. Lynch, H.H. Weitz, S. Fertel, and G.J. Merli Use of enoxaparin for the chronically anticoagulated patient before and after procedures Am J Cardiol 84 1999 478 480
9. J.D. Douketis, K. Woods, G.A. Foster, and M.A. Crowther Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery Thromb Haemost 94 3 2005 528 531
10. A.P. Annala, P.P. Karjalainen, P. Porela, K. Nyman, A. Ylitalo, and K.E. Airaksinen Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment Am J Cardiol 102 4 2008 386 390
11. E. Jamula, N.S. Lloyd, J.D. Schwalm, K.E. Airaksinen, and J.D. Douketis Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis Chest 138 4 2010 840 847
12. I. Ahmed, E. Gertner, W.B. Nelson, C.M. House, R. Dahiya, and C.P. Anderson Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation Heart Rhythm 7 6 2010 745 749
13. M. Finlay, V. Sawhney, R. Schilling, G. Thomas, E. Duncan, and R. Hunter Uninterrupted warfarin for periprocedural anticoagulation in catheter ablation of typical atrial flutter: a safe and cost-effective strategy J Cardiovasc Electrophysiol 21 2 2010 150 154
14. R.W. Hobson, W.C. Mackey, and E. Ascher Management of atherosclerotic carotid artery disease: Clinical practice guidelines of the Society for Vascular Surgery J Vasc Surg 48 2008 480 486
15. North American Symptomatic Carotid Endarterectomy Trial Collaborators Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis N Engl J Med 325 1991 445 453
16. G. Faggioli, M. Ferri, C. Rapezzi, C. Tonon, L. Manzoli, and A. Stella Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy J Vasc Surg 49 1 2009 Jan 80 85
17. O. Joakimsen, K.H. Bonaa, and E. Stensland-Bugge Reproducibility of ultrasound assessment of carotid plaque occurrence, thickness, and morphology. The Tromso Study Stroke 28 11 1997 Nov 2201 2207
18. The GUSTO investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 10 1993 Sep 2 673 682
19. J.H. Chesebro, G. Knatterud, R. Roberts, J. Borer, L.S. Cohen, and J. Dalen Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation 76 1 1987 Jul 142 154
20. G. Faggioli, M. Ferri, M. Gargiulo, A. Freyrie, F. Fratesi, and L. Manzoli Measurement and impact of proximal and distal tortuosity in carotid stenting procedures J Vasc Surg 46 2007 1119 1124
21. R.J. Chang, T.M. Doherty, and S.L. Goldberg How does warfarin affect the activated coagulation time? Am Heart J 136 3 1998 477 479
22. D.B. Jessup, A.T. Coletti, J.B. Muhlestein, W.H. Barry, F.C. Shean, and B.K. Whisenant Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy Catheter Cardiovasc Interv 60 2 2003 180 184
23. R.D. Hull, G.E. Raskob, D. Rosenbloom, A.A. Panju, P. Brill-Edwards, and J.S. Ginsberg Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis N Engl J Med 322 1990 1260 1264
24. Y.C. Chan, D. Valenti, A.O. Mansfield, and G. Stansby Warfarin induced skin necrosis Br J Surg 87 2000 266 272
25. N. Seshadri, S.Z. Goldhaber, U. Elkayam, R.A. Grimm, J.B. Groce III, and J.A. Heit The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients Am Heart J 150 1 2005 Jul 27 34
26. K.E. Airaksinen, A. Schlitt, A. Rubboli, P. Karjalainen, and G.Y. Lip How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"? EuroIntervention 6 4 2010 Sep 520 526